When a cancer patient develops a side effect during immunotherapy, oncologists often see it as a good sign — evidence that ...

The "Checkpoint Inhibitor Refractory Cancer Market – Growth, Share, Opportunities & Competitive Analysis, 2025–2035" report ...

Please provide your email address to receive an email when new articles are posted on . Adding immune checkpoint inhibitors to neoadjuvant chemotherapy benefited certain patients with early-stage ...

Checkpoint inhibitors are a groundbreaking class of cancer treatment, but they come with two frustrating challenges. In some cases, tumors show no initial response, rendering the therapy ineffective ...

Report Tracks Roche Diagnostics, Thermo Fisher, Illumina, Agilent and Guardant Health Among 132 Companies, With Forecasts by Assay Type, Technology, Customer and CountryDublin, Oct. 16, 2026 (GLOBE ...

A network meta-analysis of eight randomized trials finds that immune checkpoint inhibitors combined with anti-VEGF therapy ...

For many people diagnosed with cancer, treatment with immune checkpoint inhibitors (ICIs) has dramatically extended lives. Some of these treatments, such as Keytruda and Opdivo, have become familiar ...

Please provide your email address to receive an email when new articles are posted on . DESTIN, Fla. — Inflammatory arthritis as a result of immune checkpoint cancer therapy remains a pressing ...

Cancer immunotherapy has historically focused on harnessing the ability of T cells to recognize and attack cancer cells. Adaptive immune checkpoint inhibitors (ICIs) unleash tumor-infiltrating ...

The study showed OncoPrism-NSCLC significantly predicted overall response and identified the subset of patients with doubled ...